Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.411 EUR | 0.00% | -12.74% | -53.82% |
05-03 | Mib advances; Cucinelli confirms top spot | AN |
04-24 | Seri Industrial soars; Tessellis bearish | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 35.36 | 17.33 | 19.43 | 7.388 | 9.766 | 7.695 |
Enterprise Value (EV) 1 | 41.53 | 28.69 | 32.05 | 17.17 | 18.46 | 11.09 |
P/E ratio | -11.5 x | -13.2 x | -4.72 x | -1.29 x | -3.05 x | 1.75 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.76 x | 0.29 x | 0.42 x | 0.34 x | 0.4 x | 0.31 x |
EV / Revenue | 0.89 x | 0.49 x | 0.69 x | 0.79 x | 0.76 x | 0.45 x |
EV / EBITDA | -23.6 x | 100 x | -9.7 x | -3.42 x | -7.68 x | -2.4 x |
EV / FCF | 9.63 x | -5.88 x | -6.43 x | -4.59 x | 8.59 x | -2.18 x |
FCF Yield | 10.4% | -17% | -15.5% | -21.8% | 11.6% | -45.8% |
Price to Book | 3.1 x | 1.68 x | 3.11 x | -63.2 x | -4.19 x | 1.75 x |
Nbr of stocks (in thousands) | 5,113 | 5,113 | 5,113 | 5,113 | 5,113 | 5,113 |
Reference price 2 | 6.915 | 3.390 | 3.800 | 1.445 | 1.910 | 1.505 |
Announcement Date | 30/03/18 | 19/04/19 | 31/03/20 | 17/06/22 | 17/10/22 | 08/04/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 46.79 | 58.86 | 46.76 | 21.65 | 24.18 | 24.66 |
EBITDA 1 | -1.757 | 0.287 | -3.304 | -5.015 | -2.405 | -4.622 |
EBIT 1 | -2.559 | -0.694 | -3.832 | -5.46 | -2.745 | -4.624 |
Operating Margin | -5.47% | -1.18% | -8.2% | -25.21% | -11.35% | -18.75% |
Earnings before Tax (EBT) 1 | -2.425 | -1.248 | -4.198 | -6.044 | -3.258 | 5.547 |
Net income 1 | -3.066 | -1.314 | -4.118 | -5.708 | -3.202 | 5.967 |
Net margin | -6.55% | -2.23% | -8.81% | -26.36% | -13.24% | 24.2% |
EPS 2 | -0.6000 | -0.2570 | -0.8054 | -1.116 | -0.6262 | 0.8600 |
Free Cash Flow 1 | 4.31 | -4.876 | -4.983 | -3.737 | 2.149 | -5.078 |
FCF margin | 9.21% | -8.28% | -10.66% | -17.26% | 8.89% | -20.59% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 30/03/18 | 19/04/19 | 31/03/20 | 17/06/22 | 17/10/22 | 08/04/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | 6.17 | 11.4 | 12.6 | 9.78 | 8.7 | 3.39 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -3.511 x | 39.58 x | -3.82 x | -1.95 x | -3.615 x | -0.7343 x |
Free Cash Flow 1 | 4.31 | -4.88 | -4.98 | -3.74 | 2.15 | -5.08 |
ROE (net income / shareholders' equity) | -19.2% | -12.3% | -46.4% | -147% | 691% | 249% |
ROA (Net income/ Total Assets) | -2.71% | -0.73% | -4.45% | -7.89% | -4.34% | -7.76% |
Assets 1 | 112.9 | 180.6 | 92.61 | 72.36 | 73.72 | -76.89 |
Book Value Per Share 2 | 2.230 | 2.020 | 1.220 | -0.0200 | -0.4600 | 0.8600 |
Cash Flow per Share 2 | 2.250 | 1.280 | 0.8000 | 0.9500 | 1.030 | 0.7000 |
Capex 1 | 1.81 | 0.95 | 0.33 | 0.18 | 0.03 | 0.09 |
Capex / Sales | 3.88% | 1.61% | 0.71% | 0.85% | 0.12% | 0.38% |
Announcement Date | 30/03/18 | 19/04/19 | 31/03/20 | 17/06/22 | 17/10/22 | 08/04/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-53.82% | 13.7M | |
+5.18% | 15.5B | |
+42.08% | 5.51B | |
-7.62% | 4.77B | |
-12.11% | 4.67B | |
-7.50% | 4.53B | |
+17.17% | 4.47B | |
+13.16% | 3.79B | |
+45.85% | 3.7B | |
+2.48% | 3.32B |
- Stock Market
- Equities
- FDA Stock
- Financials Fidia S.p.A.